Blaze Therapeutics is Dedicated to Establishing a
Responsible Holistic Product Industry
Research & Development of Plant Derived Therapeutics and Nutraceuticals
Blaze Therapeutics supports the drug development process utilizing the pathway towards FDA approval of plant based therapeutics and adjunct therapies for rare diseases. Blaze Therapeutics regularly advises on plant derived nutraceuticals that are being explored for a variety of indications.
Responsible Distribution to the Healthcare Industry
Blaze Therapeutics practices Responsible Distribution of plant derived products, master distribution to the healthcare and nutraceutical sectors. The Responsible Distribution model and the Unbiased Third Party Testing requirement for Cannabis derived products are designed to identify products that have a high therapeutic potential for members of the rare disease, veteran and chronic illness communities and to PREVENT the distribution of products that are contaminated with toxins and/or do not meet label claims.
Cannabis Medicine & Science Certification Programs
It is not enough to Responsibly Distribute Cannabis derived products, like CBD, to the healthcare industry. Industry professionals need to understand the basics behind the Endocannabinoid System and Cannabis medicine or science to avoid and/or warn against unwanted side effects. Blaze Therapeutics supports professional continuing education courses through the Cannabis medicine and Cannabis science certification programs.
We care about
improving & protecting
What is responsible distribution?
Responsible Distribution (RD) is a distribution model designed specifically for the healthcare industry, with precautions taken to protect for consumer safety. The RD model requires each product to undergo an evaluation for it's therapeutic potential and label claims for compliance. Once the product is identified as qualifying for Responsible Distribution, each batch/lot of high risk products (i.e. cannabis, spices, honey, etc.) must undergo Unbiased Third Party Testing before being distributed to the market and consumers.
responsible distributioN OF CANNABIS DERIVED PRODUCTS (CBD)
Blaze Therapeutic regularly evaluates a variety of Cannabis derived products (specifically derived from hemp), available on the open legal market to see if they qualify for Responsible Distribution.
Once a product is evaluated and positively identified as having a high therapeutic potential, it is allowed to enter Blaze Therapeutic's Responsible Distribution facility for Unbiased Third Party Testing.
At the Responsible Distribution facility, a product from each batch/lot is pulled and sent to an ISO certified laboratory to undergo unbiased third party testing.
Unbiased third party laboratory tests are paid for by an unbiased third party company. In order for a third party company to be unbiased, the company submitting the product to be tested cannot be a manufacturer or brand owner of the product and must not have any financial interests in the product's brand.
Blaze Therapeutics is currently the only unbiased 3rd party company that practices Responsible Distribution in the Cannabis industry.
Should the unbiased third party test show that the batch/lot tested positive for any harmful levels of toxins, pesticides, heavy metals, microbiology, residual solvents, incorrect cannabinoid label claims, or have any other issues with inaccurate label claims, the entire batch/lot is rejected and returned to the manufacturer.
80% of CBD products FAIL Unbiased 3rd Party laboratory testing for high levels of toxins and/or inaccurate cannabinoid content when compared to its label claims.
Should the unbiased third party test show that the batch/lot passed, the entire batch/lot receives the Responsibly Distributed seal and gets distributed to the healthcare sector (i.e. pharmacies, doctor offices, hospitals, clinics, dispensaries, etc.) located throughout the United States.
The online Shop at Blaze Therapeutics provides online shoppers with access to excess and/or discontinued Responsibly Distributed inventory. While Blaze Therapeutics' Responsible Distribution model primarily caters to the healthcare brick & mortar businesses (i.e pharmacies, clinics, doctor offices, etc.), the online shop allows Blaze Therapeutics to make over-flow inventory of Responsibly Distributed products available directly to the consumers that are interested in purchasing hemp derived products that have undergone Unbiased 3rd Party Testing and Responsible Distribution. For more information regarding the products made available online, do not hesitate to contact us.